Italy (IT)

The EANM guideline for radiosynoviorthesis (2021) Kampen WU, Boddenberg-Paetzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M, Kresnik E, et al. Journal article Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex (2021) Bongaarts A, Mijnsbergen C, Anink JJ, Jansen FE, Spliet WG, den Dunnen WF, Coras R, et al. Journal article Deficit in knee extension strength following anterior cruciate ligament reconstruction is explained by a reduced neural drive to the vasti muscles (2021) Nuccio S, Del Vecchio A, Casolo A, Labanca L, Rocchi JE, Felici F, Macaluso A, et al. Journal article Physicians' Opinion and Practice With the Continuous Use of Sedatives in the Last Days of Life (2021) Heijltjes MT, Morita T, Mori M, Heckel M, Klein C, Stiel S, Miccinesi G, et al. Journal article Expanding the Chemical Space of Tetracyanobuta-1,3-diene (TCBD) through a Cyano-Diels-Alder Reaction: Synthesis, Structure, and Physicochemical Properties of an Anthryl-fused-TCBD Derivative (2021) Mateo LM, Sagresti L, Luo Y, Guldi DM, Torres T, Brancato G, Bottari G Journal article Room-Temperature On-Spin-Switching and Tuning in a Porphyrin-Based Multifunctional Interface (2021) Sturmeit HM, Cojocariu I, Windischbacher A, Puschnig P, Piamonteze C, Jugovac M, Sala A, et al. Journal article Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey (2021) Hernando J, Lamarca A, Cives M, Caplin ME, Pavel ME Conference contribution